2159 — Mediwelcome Healthcare Management & Technology Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$79.00m
- HK$22.83m
- CNY331.31m
- 18
- 57
- 21
- 18
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 26 | 22.3 | 5.59 | -91 | -96.4 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 5.33 | 1.24 | 6.29 | 12.7 | 22.5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -37.5 | -10.1 | -31.1 | 39.2 | -22.2 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 4.51 | 31.1 | 0.262 | -18.5 | -75.6 |
Capital Expenditures | -13 | -13.8 | -25 | -4.3 | -1.6 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -11.5 | 2.83 | 8.22 | -4.06 | 18.1 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -24.5 | -11 | -16.8 | -8.36 | 16.5 |
Financing Cash Flow Items | -0.309 | -0.896 | -1.26 | -1.25 | -1.3 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -5.55 | -4.79 | 92.8 | 0.054 | 0.906 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -25.6 | 15.3 | 76.3 | -26.8 | -58.2 |